Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia

Hepatocellular carcinoma (HCC) can be produced from aflatoxin B1 (AFB1) administration. Although berberine (BER) acts as an anticancer agent and can counteract the AFB1 effect, it has low bioavailability. Nano...

Source: BMC Clinical Pharmacology - August 10, 2023 Category: Drugs & Pharmacology Authors: Sarah M. Khedr, Doaa A. Ghareeb, Shadia A. Fathy and Germine M. Hamdy Tags: Research Source Type: research